Skip to main content
. 2021 Sep 1;321(5):L892–L899. doi: 10.1152/ajplung.00434.2020

Table 1.

Respiratory manifestations in Down syndrome

Area/Region Manifestations Possible Mechanisms References
Upper airways Macroglossia Hypermethylation of HOXB cluster
Hypermethylation of HOXB cluster
Hypermethylation of HOXB cluster
Hypermethylation of HOXB cluster
Hypermethylation of HOXB cluster
Hypermethylation of HOXB cluster
PCNT
(8)
Adenotonsillar hypertrophy (8)
Laryngomalacia (8)
Narrow trachea/tracheomalacia (2, 9, 10)
Tracheal bronchus (9)
Obstruction (2, 8, 11)
Ciliopathies/increased mucus production (12, 13)
Lower airways Recurrent infection

Poor airway clearance
Cytokine/chemokine storm
↑ IFN pathway
PCNT
(14, 15, 16, 17, 18, 19)
(14, 15, 16, 17, 18, 19)
(12, 13)
Alveolar space Pulmonary hypoplasia
Subpleural cysts
COL6A1
COL6A1
(20, 21, 22)
(23)
Vascular Pulmonary hypertension

Pulmonary hemosiderosis

Pulmonary capillaritis
COL18A1, APP, TIMP3, COL4A3, RCAN1, DSCR1
↓Clotting factors (F2, F5, F7, F12)
COL18A1, APP, TIMP3, COL4A3, RCAN1, DSCR1
↓Clotting factors (F2, F5, F7, F12)
COL18A1, APP, TIMP3, COL4A3, RCAN1, DSCR1
↓Clotting factors (F2, F5, F7, F12)
(4, 24, 25)
(21)
(26, 27)
(21)
(28)
(21)

Lymphatics

Lymphangiectasia

SHH, VEGF-A, PDG-B
↓FOXC2
↑IFN pathways

(12, 29)
(21, 29)
(21, 29)

Disease manifestations are listed by region of the lung affected.